Medical device industry groups are pushing back against the government's proposed regulatory framework. Eleven medtech groups have written to Union Health Minister J P Nadda seeking a separate law for medical devices.
India’s diagnostic network is expanding as healthcare companies add advanced imaging and pathology services.
Today’s pharma news highlights major drug launches, drug approvals and financial developments across respiratory care, obesity treatment and generic medicines
Cancer care continues to evolve rapidly as global and Indian pharmaceutical companies intensify efforts across drug development, partnerships, and access programs.
Samsung Bioepis has launched its aflibercept biosimilar OPUVIZ in both vial and pre-filled syringe formats, marking an entry to Europe’s eye drug market
India could become more than a market for CAR-T therapy. For Immuneel Therapeutics, it could become the base for global CAR-T growth. The Bengaluru-based biotech is building manufacturing capacity for India and future exports.
The wellness market in India enters a transformative phase as Warburg Pincus moves to acquire Universal Nutriscience
Akums Drugs and Pharmaceuticals has started FY27 on a strong note, with Q1 profit surging 55 percent year-on-year.
The latest developments highlight CDMO deals, Q1 earnings, and AI medtech transformation as key drivers shaping the pharmaceutical sector
India’s healthcare sector saw major funding, partnerships, investments, expansion plans, and pharma developments this week. KKR moved to acquire Medicover India in a USD 1.5 billion healthcare deal. Cipla and Rocket India announced...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")